Effects of Living High-Training Low and High on Body Composition and Metabolic Risk Markers in Overweight and Obese Females
Table 4
Changes in the serum lipid profile after 4 weeks of the intervention.
Variable
Pre
Post
value (interaction effect)
η2 (effect size)
FFA, mmol/L
NG
0.46 ± 0.11
0.79 ± 0.30$
0.206
0.098
HG
0.55 ± 0.20
1.05 ± 0.26$
TGs, mmol/L
NG
1.05 ± 0.33
0.85 ± 0.18
0.554
0.021
HG
0.97 ± 0.30
0.85 ± 0.13
TC, mmol/L
NG
4.49 ± 0.79
3.87 ± 0.43$
0.040
0.225
HG
4.37 ± 1.16
4.32 ± 0.99
LDL-C, mmol/L
NG
2.50 ± 0.75
2.34 ± 0.34
0.545
0.022
HG
2.50 ± 0.93
2.52 ± 0.75
HDL-C, mmol/L
NG
1.29 ± 0.22
1.11 ± 0.19&
0.055
0.200
HG
1.27 ± 0.20
1.30 ± 0.33
LDL-C/HDL-C
NG
1.96 ± 0.53
2.16 ± 0.50
0.305
0.062
HG
2.04 ± 0.98
2.04 ± 0.82
APO-A1, g/L
NG
1.16 ± 0.16
1.00 ± 0.13$
0.042
0.221
HG
1.23 ± 0.14
1.17 ± 0.23
APO-B, g/L
NG
0.72 ± 0.16
0.67 ± 0.10
0.203
0.094
HG
0.70 ± 0.26
0.71 ± 0.19
APO-A1/APO-B
NG
1.69 ± 0.42
1.54 ± 0.38$
0.566
0.020
HG
1.90 ± 0.50
1.71 ± 0.43$
Pre, preintervention. Post, postintervention. $;&, pre versus post. NG: normoxic group; HG: hypoxic group; FFA: free fatty acid; TC: total cholesterol; TGs: total triglycerides; LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol; APO-A1 and APO-B: apolipoprotein A1 and apolipoprotein B.